Related Experiment Video
Updated: Aug 26, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Antibiotic Initiation Timing and Mortality in Trauma Patients With Ventilator-Associated Pneumonia
Jacob C O'Dell1, Bachar N Halimeh2, James Johnston1
1Division of Trauma Critical Care and Acute Care Surgery, Department of Surgery, University of Kansas Medical Center, Kansas City, KS, USA.
Insights
In trauma patients with ventilator-associated pneumonia (VAP), delayed antibiotic initiation was associated with survival. This challenges the standard practice of early antibiotic administration for suspected infections in this population.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Trauma Surgery
Background:
- Early antibiotic initiation is standard for ventilator-associated pneumonia (VAP).
- Evidence for early antibiotics in trauma VAP is lacking.
- This study investigates antibiotic timing and mortality in trauma VAP.
Purpose of the Study:
- To evaluate the impact of antibiotic administration timing on in-hospital mortality.
- To assess the necessity of early antibiotic initiation in trauma patients with VAP.
Main Methods:
- Retrospective case-control study (2016-2020) at a level 1 trauma center.
- Included trauma patients with TQIP-defined VAP, stratified by mortality.
- Analyzed time from airway culture to antibiotic initiation.
Main Results:
- No significant differences in baseline characteristics or organisms between survivors and non-survivors.
- Median time to antibiotics was 2 hours for survivors vs. 0 hours for non-survivors (P=.07).
- Antibiotics within 1 hour occurred in 33.3% of survivors vs. 77.8% of non-survivors (P=.02).
Conclusions:
- Trauma VAP survivors received antibiotics later than non-survivors.
- Findings question the universal need for early antibiotic administration in suspected VAP.
- Delayed antibiotic initiation may be viable in specific trauma populations.
Background:
Early antibiotic initiation is considered a cornerstone in the management of ventilator-associated pneumonia (VAP). However, recent data suggests that early antibiotic initiation may not be necessary in all cases. Additionally, the benefits of early antibiotic administration for infection have not been studied in a dedicated trauma population. This study's aim was to evaluate the impact of antibiotic administration timing on in-hospital mortality in trauma patients with VAP.
Methods:
This retrospective case-control study identified all trauma patients at a single level 1 academic trauma center from 2016 to 2020. Patients with a TQIP-defined VAP were included and stratified into 2 subgroups by in-hospital mortality. Time interval between airway culture and antibiotic initiation was gathered. Baseline measures of injury and illness severity were collected. Univariate analysis of the data was performed.
Results:
Forty-five patients met inclusion criteria. Overall, 80% of patients survived admission (n = 36) and 20% of patients did not survive admission (n = 9). There were no significant differences in baseline characteristics or cultured organism between survivors and non-survivors. The median time interval between airway culture and antibiotic initiation was 2 hours (IQR 0-4.5) for survivors, and 0 hours (IQR 0-0) for non-survivors (P = .07). Antibiotics were administered within 1 hour of airway culture for 33.3% of survivors, and 77.8% of non-survivors (P = .02).
Conclusions:
In a population of trauma patients with VAP, survivors had antibiotics initiated in more delayed fashion than non-survivors. These findings question the primacy of early antibiotic administration for suspected infection.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology